Heterozygous LOF mutations of PPARG are associated with a familial partial lipodystrophy type 3 (FPLD3) considered as a monogenic model of the common “metabolic syndrome” [177,178]. The gene discussed is PPARG; the disease is PPARG-related familial partial lipodystrophy.